Celldex Therapeutics buy Wells Fargo & Company
Start price
27.09.24
/
50%
€28.40
Target price
27.09.25
-
Performance (%)
-33.45%
Price
25.08.25
€18.90
Summary
This prediction is currently active. Massive losses of -33.45% have been the result for the BUY prediction by Wells_Fargo___Compan. This prediction currently runs until 27.09.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -10.476% | -10.476% |
| iShares Core DAX® | -0.347% | -0.149% |
| iShares Nasdaq 100 | -0.687% | 1.850% |
| iShares Nikkei 225® | -2.075% | 3.770% |
| iShares S&P 500 | 0.351% | 1.988% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) was upgraded by analysts at Wells Fargo & Company from a "hold" rating to a "strong-buy" rating.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
2.72%
25.08.25
25.08.25
